A M Janson - JoVE Visualize

Showing results (11-20 of 47) with videos related to

Pageof 5

Sort By:

Neuroreport|July 1, 1993

Codistribution of choleratoxin binding sites and tyrosine hydroxylase/FGF-2 immunoreactive nigral nerve cellsK Fuxe, B Tinner, A M Janson, et al.

Naunyn-Schmiedeberg'S Archives of Pharmacology|April 1, 1992

Inhibitory effects of the psychoactive drug modafinil on gamma-aminobutyric acid outflow from the cerebral cortex of the awake freely moving guinea-pig. Possible involvement of 5-hydroxytryptamine mechanismsS Tanganelli, K Fuxe, L Ferraro, et al.

Neuroscience Letters|December 16, 1991

Chronic nicotine treatment counteracts the decrease in extracellular neostriatal dopamine induced by a unilateral transection at the mesodiencephalic junction in rats: a microdialysis studyA M Janson, J J Meana, M Goiny, et al.

Neuroreport|December 1, 1992

Chronic nicotine treatment decreases dopamine D2 agonist binding in the rat basal gangliaA M Janson, P B Hedlund, M Hillefors, et al.

Brain Research|August 29, 1994

Chronic nicotine treatment counteracts dopamine D2 receptor upregulation induced by a partial meso-diencephalic hemitransection in the ratA M Janson, P B Hedlund, K Fuxe, et al.

Experimental Cell Research|December 10, 1999

Neural stem cells in the adult human brainC B Johansson, M Svensson, L Wallstedt, et al.

The Journal of Pharmacology and Experimental Therapeutics|January 1, 1997

(+)MK-801 does not prevent MPTP-induced loss of nigral neurons in miceP Chan, D A Di Monte, J W Langston, et al.

Experimental Neurology|April 8, 1999

Diethyldithiocarbamate causes nigral cell loss and dopamine depletion with nontoxic doses of MPTPT L Walters, I Irwin, K Delfani, et al.

Naunyn-Schmiedeberg'S Archives of Pharmacology|March 1, 1990

Chronic nicotine treatment increases dopamine levels and reduces dopamine utilization in substantia nigra and in surviving forebrain dopamine nerve terminal systems after a partial di-mesencephalic hemitransectionK Fuxe, A M Janson, A Jansson, et al.

Brain Research|September 14, 1999

7-Nitroindazole prevents 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced ATP loss in the mouse striatumJ E Royland, K Delfani, J W Langston, et al.

Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:

Pageof 5

Neuroreport|July 1, 1993

Codistribution of choleratoxin binding sites and tyrosine hydroxylase/FGF-2 immunoreactive nigral nerve cellsK Fuxe, B Tinner, A M Janson, et al.

Naunyn-Schmiedeberg'S Archives of Pharmacology|April 1, 1992

Inhibitory effects of the psychoactive drug modafinil on gamma-aminobutyric acid outflow from the cerebral cortex of the awake freely moving guinea-pig. Possible involvement of 5-hydroxytryptamine mechanismsS Tanganelli, K Fuxe, L Ferraro, et al.

Neuroscience Letters|December 16, 1991

Chronic nicotine treatment counteracts the decrease in extracellular neostriatal dopamine induced by a unilateral transection at the mesodiencephalic junction in rats: a microdialysis studyA M Janson, J J Meana, M Goiny, et al.

Neuroreport|December 1, 1992

Chronic nicotine treatment decreases dopamine D2 agonist binding in the rat basal gangliaA M Janson, P B Hedlund, M Hillefors, et al.

Brain Research|August 29, 1994

Chronic nicotine treatment counteracts dopamine D2 receptor upregulation induced by a partial meso-diencephalic hemitransection in the ratA M Janson, P B Hedlund, K Fuxe, et al.

Experimental Cell Research|December 10, 1999

Neural stem cells in the adult human brainC B Johansson, M Svensson, L Wallstedt, et al.

The Journal of Pharmacology and Experimental Therapeutics|January 1, 1997

(+)MK-801 does not prevent MPTP-induced loss of nigral neurons in miceP Chan, D A Di Monte, J W Langston, et al.

Experimental Neurology|April 8, 1999

Diethyldithiocarbamate causes nigral cell loss and dopamine depletion with nontoxic doses of MPTPT L Walters, I Irwin, K Delfani, et al.

Naunyn-Schmiedeberg'S Archives of Pharmacology|March 1, 1990

Chronic nicotine treatment increases dopamine levels and reduces dopamine utilization in substantia nigra and in surviving forebrain dopamine nerve terminal systems after a partial di-mesencephalic hemitransectionK Fuxe, A M Janson, A Jansson, et al.

Brain Research|September 14, 1999

7-Nitroindazole prevents 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced ATP loss in the mouse striatumJ E Royland, K Delfani, J W Langston, et al.

Pageof 5